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Abstract
Background: The purpose of the present investigation was to determine the effects of EPA/DHA
supplementation on resting and exercise-induced inflammation and oxidative stress in exercise-
trained men. Fourteen men supplemented with 2224 mg EPA+2208 mg DHA and a placebo for 6
weeks in a random order, double blind cross-over design (with an 8 week washout) prior to
performing a 60 minute treadmill climb using a weighted pack. Blood was collected pre and post
exercise and analyzed for a variety of oxidative stress and inflammatory biomarkers. Blood lactate,
muscle soreness, and creatine kinase activity were also measured.
Results: Treatment with EPA/DHA resulted in a significant increase in blood levels of both EPA
(18 ± 2 μmol·L-1 vs. 143 ± 23 μmol·L-1; p < 0.0001) and DHA (67 ± 4 μmol·L-1 vs. 157 ± 13 μmol·L-
1; p < 0.0001), while no differences were noted for placebo. Resting levels of CRP and TNF-α were
lower with EPA/DHA compared to placebo (p < 0.05). Resting oxidative stress markers were not
different (p > 0.05). There was a mild increase in oxidative stress in response to exercise (XO and
H2O2) (p < 0.05). No interaction effects were noted. However, a condition effect was noted for
CRP and TNF-α, with lower values with the EPA/DHA condition.
Conclusion: EPA/DHA supplementation increases blood levels of these fatty acids and results in
decreased resting levels of inflammatory biomarkers in exercise-trained men, but does not appear
necessary for exercise-induced attenuation in either inflammation or oxidative stress. This may be
due to the finding that trained men exhibit a minimal increase in both inflammation and oxidative
stress in response to moderate duration (60 minute) aerobic exercise.
Background
Oxidative stress is a condition in which the production of
reactive oxygen and nitrogen species (RONS) overwhelms
the body's available antioxidant defenses, possibly result-
ing in oxidation within susceptible tissues [1]. This has
been reported in response to both aerobic [2] and anaer-
obic [3] exercise, with over 300 original investigations
published over the past 30 years [2]. While a low level of
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RONS production is necessary to maintain normal physi-
ological function [4], as well as to allow for exercise-
induced adaptations to the endogenous antioxidant
defense system [5,6], excessive production of RONS can
lead to the oxidation of lipids, proteins, and nucleic acids,
potentially altering normal cellular function [7]. For
example, acute and significant elevations in RONS may
impair muscle force production [8], while more pro-
longed RONS production (possibly resulting from exer-
cise overtraining) may impede exercise recovery [9]. Due
to the association between increased RONS production
and the pathogenesis of human disease, it has been an
objective of some to regulate the oxidative stress response
to acute exercise. Although somewhat controversial (See
[10]), this is often done via the use of antioxidant nutri-
ents.
In addition to RONS production and subsequent oxida-
tive stress resulting from strenuous exercise, an often asso-
ciated finding is acute and chronic inflammation [11-13].
In light of the relationship between RONS and inflamma-
tion, and the commonly measured biomarkers C-reactive
protein (CRP) and tumor necrosis factor-alpha (TNF-α),
inflammation is often increased in response to strenuous
exercise [12-16]. In the short term, this appears to serve as
a healing mechanism; however, chronic systemic inflam-
mation (as with chronic systemic oxidative stress) has
been associated with disease pathology [17]. Hence,
methods of reducing systemic inflammation, such as the
performance of regular physical activity [18], weight loss
[19], and the use of dietary supplements [17] have been
considered.
One class of nutrients that appears to possess both anti-
oxidant and anti-inflammatory effects is essential fatty
acids such as the fish oils eicosapentaenoic acid (EPA) and
docosahexaenoic acid (DHA). While some reports have
noted a decrease in resting oxidative stress and inflamma-
tory biomarkers with EPA and DHA treatment [20-22],
few studies have determined the effects of such supple-
mentation in human subjects on exercise-induced
changes in these measures [23-25]. In the few studies that
have been conducted, results have been mixed, with issues
such as the exercise protocol, test subjects (trained and
untrained), dosage and duration of supplementation, the
timing of measurement, and selection of biomarkers
likely contributing to the discrepancies. Because so few
studies investigating the effects of EPA/DHA supplemen-
tation have included exercise-trained individuals as
research subjects, such individuals were used in the
present study. This is because such dietary supplements
are often promoted as being beneficial to these individu-
als for purposes of attenuating the oxidative stress and
inflammatory response to exercise. It was our objective to
determine if EPA/DHA supplementation is needed by
exercise-trained individuals for these purposes.
Therefore, it was the purpose of this study to determine
the effects of six weeks of EPA/DHA supplementation on
resting and exercise-induced oxidative stress and inflam-
mation in exercise-trained men. It was hypothesized that
1) EPA/DHA would result in a lowering of resting inflam-
matory and oxidative stress biomarkers, 2) that exercise
would induce oxidative stress and inflammation follow-
ing the use of both EPA/DHA and placebo, and 3) that
EPA/DHA would attenuate the exercise-induced rise in
these biomarkers, compared to placebo.
Methods
Subjects and screening
Only exercise-trained men were recruited to participate.
Subjects were required to exercise both aerobically and
anaerobically at least three days per week for a minimum
of 30 minutes per session (for each type of exercise) for
the past 12 months. In addition, subjects must have had
an aerobic power (VO2max) of at least 40 mL·kg-1·min-1.
Subjects were nonsmokers, not using anti-inflammatory
or antioxidant agents, and did not report any history of
cardiovascular or metabolic disorders.
Health history, drug and dietary supplement usage, and
physical activity questionnaires were completed by all
subjects to determine eligibility. Prior to participation,
each subject was informed of all procedures, potential
risks, and benefits associated with the study through both
verbal and written form in accordance with the approved
procedures of the University Institutional Review Board
for Human Subjects Research. Potential recruits signed an
informed consent form prior to being admitted as a sub-
ject.
Subjects' height, weight, and body composition via 7 site
skinfold test and calculation using Siri equation was
measured. Heart rate and blood pressure were recorded
following a 10 minute period of quiet rest. Subject charac-
teristics are shown in Table 1. It should be noted that of
the 15 men included in the study, 13 were Caucasian and
two were African American. A full explanation of dietary
and physical activity data recording was provided to sub-
jects, along with data collection forms. An overview of
study procedures was also provided.
A maximal graded exercise test (GXT) was conducted
using a treadmill while expired gases were collected via
facemask and analyzed using a SensorMedics Vmax 229™
metabolic system for determination of maximal oxygen
consumption (VO2max). The collection and analysis of
expired gases provided further descriptive characteristics
regarding participants' aerobic power (e.g., VO2max). The
test continued until volitional fatigue. Before and during
the GXT, heart rate was continuously monitored via elec-
trocardiograph (ECG) tracings using a SensorMedics Max-
1™ ECG unit. Expired oxygen and respiratory exchangeLipids in Health and Disease 2009, 8:36 http://www.lipidworld.com/content/8/1/36
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ratio data were continuously monitored via breath-by-
breath samples. Blood pressure was monitored and the
Borg scale of exertion was used to allow participants to
indicate their level of perceived work. The highest 30 sec-
ond average for VO2 was recorded as subjects' VO2max. Five
subjects who underwent testing failed to reach the 40
mL·kg-1·min-1 criteria. Therefore, these individuals were
excluded from participation, leaving us with a total of 15
subjects entering randomization.
Supplementation
The study design involved a random order cross-over
assignment to EPA/DHA and placebo in a double blind
manner. A schematic of the study timeline is presented in
Figure 1. The total daily dosage of EPA (2224 mg; MorEPA
Mini; Minami Nutrition, Belgium) and DHA (2208 mg;
MorDHA Mini; Minami Nutrition, Belgium) was pro-
vided in eight gel capsules taken twice per day (morning
and evening) with meals. The placebo gel capsules (taken
in the same quantities) consisted of soybean oil and were
identical in appearance, texture, and taste to the EPA/DHA
capsules.
In both conditions, capsules were distributed to subjects
by research assistants every two weeks in unlabeled boxes
in amounts greater than needed for supplementation.
Capsule counts upon box return allowed for estimation of
compliance to intake.
Acute exercise session
Following each six week period of EPA/DHA or placebo
intake, subjects reported to the lab in the morning to per-
form a submaximal exercise test. Subjects were asked to
walk on a treadmill while carrying a weighted backpack
(weight equal to 25% of body mass) for 60 minutes. The
treadmill speed and grade were altered every five minutes
Table 1: Descriptive characteristics of 14 exercise-trained men
Variable Value
Age (yrs) 25.5 ± 4.8
Height (cm) 174.4 ± 6.2
Weight (kg) 73.4 ± 7.7
Body fat (%) 10.0 ± 3.6
BMI (kg·m-2) 24.1 ± 1.6
Resting HR (bpm) 56 ± 8.7
Resting SBP(mmHg) 112.1 ± 9.8
Resting DBP(mmHg) 68.6 ± 7.2
VO2max (mL·kg-1·min-1) 47.0 ± 3.5
Years Aerobic Exercise 3.9 ± 3.6
Hours/wk Aerobic Exercise 4.4 ± 3.8
Years Anaerobic Exercise 6.3 ± 3.8
Hours/wk Anaerobic Exercise 5.3 ± 3.1
Data are mean ± SD.
Study timeline to investigate the effects of EPA/DHA on resting and exercise-induced inflammation and oxidative stress Figure 1
Study timeline to investigate the effects of EPA/DHA on resting and exercise-induced inflammation and oxida-
tive stress.L
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Table 2: Exercise data from 14 exercise-trained men during 60 minutes of treadmill walking
Ending 
Minute →
5 1 01 52 02 53 03 54 04 55 05 56 0
S p e e d  ( m p h ) 3 . 53 . 53 . 53 . 53 . 53 . 53 . 53 . 53 . 53 . 03 . 03 . 5
Grade
(%)
051 0 051 0 051 0 1 2 . 5 01 5
Heart Rate 
(bpm)
EPA/DHA
104.09 ± 3.46 130.42 ± 3.79 159.67 ± 5.10 122.33 ± 4.06 140.17 ± 5.34 168.33 ± 4.93 128.25 ± 4.77 148.50 ± 5.32 168.73 ± 4.85 166.64 ± 4.23 129.73 ± 3.86 183.20 ± 3.74
Heart Rate 
(bpm)
Placebo
107.18 ± 4.38 130.33 ± 4.79 161.42 ± 4.98 122.42 ± 4.23 144.42 ± 4.92 169.00 ± 4.98 131.91 ± 5.33 150.42 ± 5.80 170.09 ± 5.60 167.55 ± 5.23 130.82 ± 5.06 180.00 ± 3.83
RPE
DHA/EPA
9.67 ± 0.56 12.00 ± 0.44 15.15 ± 0.46 11.62 ± 0.45 14.08 ± 0.56 16.62 ± 0.49 12.69 ± 0.49 14.23 ± 0.67 16.92 ± 0.45 15.75 ± 0.54 12.42 ± 0.60 19.18 ± 0.23
RPE
Placebo
9.18 ± 0.67 11.77 ± 0.50 14.69 ± 0.43 11.85 ± 0.42 13.54 ± 0.37 16.23 ± 0.43 11.38 ± 0.58 14.00 ± 0.48 16.58 ± 0.31 15.83 ± 0.55 11.67 ± 0.62 19.40 ± 0.22
VO2
(L·min-1)
EPA/DHA
1.00 ± 0.12 1.81 ± 0.15 2.12 ± 0.15 1.23 ± 0.09 1.56 ± 0.16 1.91 ± 0.22 1.17 ± 0.11 1.57 ± 0.15 2.00 ± 0.13 1.86 ± 0.13 1.39 ± 0.19 2.35 ± 0.21
VO2
(L·min-1)
Placebo
0.98 ± 0.09 1.39 ± 0.14 1.98 ± 0.14 1.12 ± 0.18 1.61 ± 0.17 1.89 ± 0.15 1.15 ± 0.16 1.65 ± 0.15 2.01 ± 0.12 1.79 ± 0.11 1.16 ± 0.27 2.43 ± 0.20
RER
EPA/DHA
0.91 ± 0.01 0.97 ± 0.02 1.02 ± 0.02 1.00 ± 0.02 0.96 ± 0.03 1.00 ± 0.02 0.93 ± 0.01 0.96 ± 0.03 0.98 ± 0.02 0.96 ± 0.02 0.91 ± 0.02 1.08 ± 0.04
RER
Placebo
0.89 ± 0.01 0.95 ± 0.01 1.02 ± 0.02 0.94 ± 0.02 0.93 ± 0.03 1.02 ± 0.03 0.99 ± 0.04 0.90 ± 0.02 1.02 ± 0.03 1.00 ± 0.04 0.95 ± 0.03 1.09 ± 0.03
Data are mean ± SEM.
No statistically significant differences noted (p > 0.05).
RPE = rating of perceived exertion; RER = respiratory exchange ratioLipids in Health and Disease 2009, 8:36 http://www.lipidworld.com/content/8/1/36
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as outlined in Table 2. We chose to use a strenuous aero-
bic exercise test protocol which would result in an increase
in RONS via increased oxygen consumption, in addition
to other potential pathways (e.g., prostanoid metabolism,
the autooxidation of catecholoamines, and oxidase enzy-
matic activity (NAD(P)H oxidase, xanthine oxidase [26]).
Rather than simply use a traditional steady state aerobic
exercise protocol which would result in a moderate
increase in oxygen consumption, we attempted to mimic
a strenuous uphill climb, in which individuals perform
intermittent exercise while carrying an excess load. The
addition of the extra load would theoretically increase the
amount of work performed, resulting in a greater increase
in oxygen consumption and subsequent RONS genera-
tion via mitochondrial electron leakage. We chose such a
protocol as many previous studies using exercise-trained
individuals involved in moderate duration aerobic exer-
cise have noted minimal increase in oxidative stress and
inflammatory biomarkers [2]. Of course, we could have
also opted to use strenuous and intermittent eccentric
resistance exercise as our chosen stressor, as such exercise
often results in acute and chronic oxidative stress and
inflammation. However, our recent findings for this form
of exercise (eccentric multi-joint) indicate only minimal
increases in both oxidative stress and inflammatory
biomarkerswhen using resistance trained men as research
subjects [27]. Therefore, based on these findings of only
minimal increase in oxidative stress and inflammation
when using exercise trained subjects performing tradi-
tional aerobic or eccentric resistance exercise, we opted to
use an aerobic exercise model with an exaggerated exter-
nal load in the present design. Pilot testing was found to
result in a significant physical stress, much more so than
traditional aerobic or resistance exercise.
Because our climb was similar to that performed by the
military in a typical physical march, we consulted with a
Marine Corps ROTC Captain, in addition to information
reported in the United States Army Infantry Combat
School handbook http://www.globalsecurity.org. This
allowed for determination of the test duration and pack
load. The specific speed and grade of each stage of testing
was determined through the same consultation, in addi-
tion to pilot testing. Breath samples were collected from
subjects during the last two minutes of each five minute
stage throughout the exercise test for analysis of expired
gases (SensorMedics Vmax 229™ metabolic system). In
addition, heart rate and perceived exertion (620 Borg
scale) were recorded. Subjects completed the identical
exercise test following each six week period of EPA/DHA
or placebo intake. Although subjects performed the test in
the morning following an eight hour overnight fast, they
were allowed to drink water ad libitum before, during,
and following the exercise test. Water intake was matched
for both exercise test days.
Blood sampling
Venous blood samples (~20 mL) were taken from sub-
jects' forearm via needle and Vacutainer™. Blood samples
were collected pre and post intervention for both EPA/
DHA and placebo conditions, and analyzed for plasma
EPA and DHA concentrations using Gas Chromatogra-
phy-Flame Ionisation Detection (GC-FID). In relation to
the exercise test, blood samples were collected pre exercise
(following a 10 minute quiet rest), 0 hours post-exercise,
0.5 hours post-exercise, and 24 and 48 hours post-exer-
cise. Following collection, blood samples were processed
accordingly, and the plasma/serum was immediately
stored at -80°C until analyzed. As markers of inflamma-
tion, CRP was analyzed in serum using an ultra-sensitive
enzyme linked immunosorbent assay (ELISA) procedure
as described by the manufacturer (Diagnostic Systems
Laboratories, Webster, TX) and TNF-α was analyzed in
plasma using an ELISA procedure as described by the
manufacturer (Caymen Chemical, Ann Arbor, MI). Anti-
oxidant capacity was analyzed in serum using the Trolox-
equivalent antioxidant capacity (TEAC) assay using proce-
dures outlined by the reagent provider (Sigma Chemical,
St. Louis, MO). As markers of oxidative stress, we selected
a wide array of commonly studied variables in order to
best characterize the system. Protein carbonyls were ana-
lyzed in plasma using an ELISA procedure as described by
the manufacturer (Zenith Technologies, Dunedin, NZ).
Serum titers of IgG-autoantibodies against oxidized low
density lipoprotein (LDL) were analyzed using an ELISA
procedure as described by the manufacturer (OLAB, Bio-
medica). Malondialdehyde was analyzed in plasma using
a commercially available colorimetric assay (Northwest
Life Science Specialties, Vancouver, WA), using the modi-
fied method described by Jentzsch et al. [28]. Hydrogen
peroxide and xanthine oxidase activity were analyzed in
plasma using the Amplex Red reagent method as
described by the manufacturer (Molecular Probes, Invitro-
gen Detection Technologies, Eugene, OR). Nitric oxide
was estimated using the nitrate/nitrite assay procedure
(Caymen Chemical, Ann Arbor, MI). Whole blood lactate
(pre, 0 hours, 0.5 hours only) was analyzed using an auto-
mated unit (Accutrend; Roche Diagnostics, Mannheim,
Germany).
In order to determine any degree of muscle injury, the
common indirect markers of injury including creatine
kinase activity and muscle soreness were chosen. Creatine
kinase activity was measured spectrophotometrically
using commercially available reagents (StanBio Labs,
Boerne, TX). Muscle soreness was assessed using a 10 cm
visual analog scale where "0" represents no pain and "10"
represents intense pain [29]. Subjects reported their per-
ceived muscle soreness following body-weight squatting
(two repetitions). This was done at all blood collection
time points.Lipids in Health and Disease 2009, 8:36 http://www.lipidworld.com/content/8/1/36
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Dietary and physical activity records
All subjects were instructed to maintain their normal diet,
and record their food and beverage intake during the
seven day period prior to each exercise test day. Nutri-
tional records were analyzed for total calories, protein,
carbohydrate, fat, and a variety of micronutrients (Food
Processor SQL, version 9.9, ESHA Research, Salem, OR).
Subjects were given specific instructions regarding absti-
nence of alcohol consumption during the 48 hours imme-
diately preceding the test days. Subjects were instructed to
maintain their normal physical activity, with the excep-
tion of refraining from activity during the 48 hours pre-
ceding and following each test day.
Statistical analysis
For the main analysis, all dependent variables were ana-
lyzed using a 2 (group) × 5 (time) repeated measures anal-
ysis of variance (ANOVA). Blood EPA and DHA data were
analyzed using a 2 (group) × 2 (time) ANOVA. Significant
interactions and main effects were further analyzed using
Tukey's post hoc tests. Dietary and physical activity data
were analyzed using a t-test. All analyses were performed
using JMP statistical software (version 4.0.3, SAS Institute,
Cary, NC). Statistical significance was set at p = 0.05. The
data are presented as mean ± SEM, except for subject
descriptive characteristics (mean ± SD).
Results
Of the 15 subjects who were enrolled in the study, one
was dropped due to failure to complete the second exer-
cise test (due to injury unrelated to the study). Therefore,
only 14 subjects' data are included in the analyses. Regard-
ing compliance to capsule intake, subjects were 91% com-
pliant to EPA/DHA capsules and 97% compliant to
placebo capsules, with no statistical difference noted (p =
0.276). No difference was noted between conditions in
subjects' dietary intake for total kilocalories, total grams of
protein, percentage protein, total carbohydrate, percent-
age carbohydrate, total fat, percentage fat, vitamin C
intake, vitamin E intake, or vitamin A intake (p > 0.05).
Data are presented in Table 3.
Exercise test data
No difference was noted between conditions for heart
rate, perceived exertion, VO2, or respiratory exchange ratio
(p > 0.05). Data are presented in Table 2. Blood lactate
was increased at 0 and 0.5 hours post exercise compared
to pre exercise (p < 0.05), but not different (p > 0.05)
between EPA/DHA (pre: 1.78 ± 0.31; 0 post: 6.33 ± 0.43;
30 post: 2.86 ± 0.33 mmol·L-1) and placebo (pre: 1.86 ±
0.33; 0 post: 6.20 ± 0.46; 30 post: 2.76 ± 0.32 mmol·L-1).
Inflammatory and oxidative stress data
Treatment with EPA/DHA resulted in a significant
increase in blood levels of both EPA (18 ± 2 μmol·L-1 vs.
143 ± 23 μmol·L-1; p < 0.0001) and DHA (67 ± 4 μmol·L-
1 vs. 157 ± 13 μmol·L-1; p < 0.0001). No differences were
noted for placebo in EPA (34 ± 9 μmol·L-1 vs. 28 ± 5
μmol·L-1; p > 0.05) and DHA (98 ± 12 μmol·L-1 vs. 86 ±
7 μmol·L-1; p > 0.05).
Resting levels of CRP and TNF-α were lower with EPA/
DHA compared to placebo (p < 0.05). However, resting
oxidative stress markers were not different (p > 0.05).
There was an increase in oxidative stress in response to
exercise (time effect with regards to XO [p = 0.032] and
H2O2 [p = 0.0001]), with values for both of these variables
higher at 0 hours post exercise compared to pre exercise (p
< 0.05). No other time effects were noted. In addition, no
interaction effects were noted, perhaps due to the rela-
tively minor increase noted in these variables. However, a
condition effect was noted for both CRP (p < 0.0003) and
TNF-α (p < 0.05), with lower values with the EPA/DHA
condition. No other condition effects were noted. Inflam-
matory and oxidative stress biomarkers measured before
and after exercise are presented in Figures 2, 3, and 4.
Muscle injury data
Creatine kinase activity was not statistically increased with
exercise (p > 0.05), and very similar for both EPA/DHA
(56 ± 8, 91 ± 13, 74 ± 11, 95 ± 14, 70 ± 16 U·L-1) and pla-
cebo (66 ± 12, 90 ± 16, 75 ± 13, 87 ± 17, 89 ± 13 U·L-1)
at pre, 0, 0.5, 24, and 48 hours post exercise, respectively.
A time main effect was noted for muscle soreness (p =
0.0003) with 0 and 0.5 hours post-exercise higher than
rest (p = 0.05). No interaction effect was noted (p > 0.05),
with near identical values for EPA/DHA (0 ± 0, 3.9 ± 0.5,
2.5 ± 0.3, 1.8 ± 0.3, 1.2 ± 0.1) and placebo (0 ± 0, 3.78 ±
0.5, 3.0 ± 0.4, 2.3 ± 0.4, 1.7 ± 0.3) at pre, 0, 0.5, 24, and
48 hours post exercise, respectively.
Discussion
Findings from the present investigation indicate that EPA/
DHA supplementation at a daily dosage of 2224 mg
Table 3: Dietary data of 14 exercise-trained men during the 7 
days preceding exercise testing
Variable EPA/DHA Placebo
Kcal 2603 ± 209 2692 ± 217
Protein (g) 123 ± 9 130 ± 11
% Protein 20 ± 2 20 ± 3
CHO (g) 348 ± 33 355 ± 38
% CHO 53 ± 2 53 ± 3
Fat (g) 84 ± 9 84 ± 11
% Fat 29 ± 1 28 ± 2
Vitamin C (mg) 100 ± 24 144 ± 29
Vitamin E (mg) 13 ± 4 8 ± 3
Vitamin A (RE) 4448 ± 566 5113 ± 586
Data are mean ± SEM.
No statistically significant differences noted (p > 0.05).Lipids in Health and Disease 2009, 8:36 http://www.lipidworld.com/content/8/1/36
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Blood C-reactive protein (A), tumor necrosis factor-alpha (B), and trolox equivalent antioxidant capacity (C) in exercise- trained men before and following 60 minutes of treadmill exercise Figure 2
Blood C-reactive protein (A), tumor necrosis factor-alpha (B), and trolox equivalent antioxidant capacity (C) 
in exercise-trained men before and following 60 minutes of treadmill exercise.
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Blood protein carbonyls (A), oxidized low density lipoprotein (B), and malondialdehyde (C) in exercise-trained men before and  following 60 minutes of treadmill exercise Figure 3
Blood protein carbonyls (A), oxidized low density lipoprotein (B), and malondialdehyde (C) in exercise-trained 
men before and following 60 minutes of treadmill exercise.
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Blood hydrogen peroxide (A), xanthine oxidase activity (B), and nitrate/nitrite (C) in exercise-trained men before and following  60 minutes of treadmill exercise Figure 4
Blood hydrogen peroxide (A), xanthine oxidase activity (B), and nitrate/nitrite (C) in exercise-trained men 
before and following 60 minutes of treadmill exercise.
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EPA+2208 mg DHA for 6 weeks 1) significantly increases
blood levels of these fatty acids, 2) results in decreased
resting levels of inflammatory biomarkers, but 3) does not
appear necessary for attenuation of exercise-induced oxi-
dative stress or inflammation in a sample of exercise-
trained men. This latter finding may be due to the obser-
vation that trained men exhibit a minimal increase in
both inflammation and oxidative stress in response to a
moderate duration, aerobic exercise.
We chose to use an aerobic exercise protocol of moderate
duration in order to mimic a type and duration of exercise
commonly performed by many individuals. We included
an exaggerated external load component in our protocol
(use of a weighted backpack) in order to increase the met-
abolic demands of the exercise, which theoretically would
have increased RONS production and subsequent oxida-
tive stress. Previous studies using exercise-trained subjects
performing moderate duration aerobic or anaerobic exer-
cise bouts have largely resulted in minimal increase in oxi-
dative stress [2], likely due to the upregulation in
endogenous antioxidant protective mechanisms within
such individuals [30]. With this knowledge, we did not
want to use such an exercise protocol, with the probability
of observing an oxidative stress response being minimal.
Hence, we decided to include a moderate duration aero-
bic exercise bout with the additional load, in order to
increase the metabolic demands. To our knowledge, no
study to date has used such a protocol in an attempt to
elicit an oxidative stress response. Our findings of a lack of
such response within our sample of exercise-trained men
provide additional evidence that individuals who engage
in regular, strenuous exercise experience minimal oxida-
tive stress in response to moderate duration aerobic exer-
cise bouts, even when such bouts are strenuous in nature
(as evidenced by our blood lactate, heart rate, and per-
ceived exertion dataTable 2).
Due to these observations, we conclude that supplemen-
tal antioxidant/anti-inflammatory agents such as EPA/
DHA are not necessary for such individuals, as the oxida-
tive stress and inflammatory response is minimal. There is
simply no additional need for such exogenous protection.
This does not indicate, however, that use of EPA/DHA
may not prove beneficial for either untrained individuals
who are beginning an exercise program (whether for rec-
reation or therapeutic reasons), or for individuals engaged
in longer duration exercise involving extensive muscle
injury. Such situations may lead to increased RONS for-
mation, inflammation, and muscle injury. Under these
conditions, supplemental EPA/DHA may prove benefi-
cialbased on our findings of decreased CRP and TNF-α. Of
course, further research is necessary to verify this hypoth-
esis.
Oxidative stress has been reported to be elevated in
response to acute exercise in several investigations,
although this is not always the case [2]. The findings for
increased oxidative stress are relatively uniform when
untrained subjects are used within the research design. Of
course, the downside to such work is that the results can-
not be generalized to a population of exercise-trained sub-
jects. Considering that dietary supplements for purposes
of muscle recovery following exercise are typically mar-
keted to individuals engaged in regular exercise, studies
including untrained individuals may provide little infor-
mation as it relates to the target population. For this rea-
son, trained subjects were selected for this experiment.
In contrast to the findings for increased oxidative stress in
response to exercise in untrained subjects, several studies
using exercise-trained individuals have reported minimal
increase in exercise-induced oxidative stress, when exer-
cise bouts are of moderate duration (= 60 minutes) and
intensity (= 70% VO2max) [2]. More consistent findings of
elevated oxidative stress in exercise-trained subjects are
available for long duration exercise bouts, often involving
marathon or triathlon competition [2]. It is possible that
antioxidant/anti-inflammatory supplements may be ben-
eficial for such individuals during these times, as some
studies have reported attenuation in exercise-induced oxi-
dative stress/inflammation with use of such agents
[15,25,31-35]. Considering that excessive oxidative stress
[7] and inflammation [17] has been linked to the devel-
opment and progression of several chronic diseases, use of
agents in an attempt to minimize (but not eliminate)
increases in both oxidative stress and inflammation may
be reasonable. This is especially true for individuals who
are routinely involved in excessive strenuous exercise, as
such an activity pattern has been associated with ill-health
and premature death [36]. However, specific data address-
ing this issue are certainly needed.
Considering the above, coupled with the findings of the
present study, it is possible that our chosen exercise proto-
col was of too low an intensity and duration to promote a
significant oxidative stress, in particular within our sam-
ple of exercise-trained men. The production of RONS has
been reported to increase in an intensity [37,38] and dura-
tion dependent manner [39]. Therefore, we may have
observed a greater magnitude of increase in our chosen
biomarkers if the exercise bout was extended in duration
and was more intense. That being said, it should be under-
stood that increasing either of these variables would have
made it extremely difficult for subjects to complete the
protocol. Most were visibly exhausted at the conclusion of
testing, and commented on the extreme difficulty of the
protocol. We believe that our findings confirm previous
reports which indicate that even with strenuous exercise ofLipids in Health and Disease 2009, 8:36 http://www.lipidworld.com/content/8/1/36
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moderate duration; individuals who are exercise-trained
experience minimal increase in exercise-induced oxidative
stress and inflammation. This lack of response is likely
one of the additional and often overlooked benefits of
regular exercise training; that is, an upregulation in endog-
enous antioxidant defense mechanisms [6,30,40]. These
findings have applicability to most individuals who
include exercise as a component of their daily routine.
Specifically, only a small percentage of exercise enthusi-
asts typically train for longer than one hour per session.
Our findings have specificity towards such individuals,
even when the exercise training is rather challenging.
Given that the chosen protocol was concentric in nature,
the amount of muscle damage (and subsequent related
RONS production) would be expected to be minimal.
This was confirmed by our findings of insignificant
increases in muscle soreness and creatine kinase activity in
blood. Our results may have been different if using either
an aerobic exercise bout involving an eccentric bias (e.g.,
downgrade running) or a heavy resistance exercise proto-
col involving a great degree of eccentric muscle actions.
However, as mentioned earlier, our recent findings using
trained men performing eccentric multi-joint resistance
exercise indicate only a minimal increase in both oxida-
tive stress and inflammatory biomarkers [27]. Therefore,
we opted to use an aerobic exercise model with an exag-
gerated external load in an attempt to stimulate a further
increase in RONS via increased mitochondrial electron
leakage.
As with oxidative stress, prior research has shown that the
exercise-induced inflammatory response is intensity [11]
and duration [41] dependent. In the same way that our
protocol may have been of too low an intensity and dura-
tion to significantly increase oxidative stress biomarkers,
this may have also been true for CRP and TNF-α. This is
underscored by the finding of Mastaloudis et al. [14], who
reported elevated CRP, TNF-α, and interleukin-6 (IL-6) in
athletes performing a 50 km ultra-marathon. TNF-α and
IL-6 were elevated significantly as early as mid-race, while
CRP reached significance in the hours following the race,
peaking at 24 hours, and remaining 2 fold higher than
baseline at the 6th day of recovery. These findings are in
contrast to those of the present study in which CRP and
TNF-α were not altered in a statistically significant man-
ner, even through 48 hours into recovery.
Conclusion
Supplementation with EPA/DHA increases blood levels of
these fatty acids and is associated with a decrease in rest-
ing CRP and TNF-α. However, EPA/DHA supplementa-
tion does not appear necessary for attenuation of exercise-
induced oxidative stress or inflammation in a sample of
exercise-trained men. Such individuals experience a mini-
mal increase in oxidative stress and inflammation in
response to a moderate duration, aerobic exercise. Hence,
EPA/DHA supplementation should not be specifically rec-
ommended for this purpose. Future studies investigating
the effect of antioxidant/anti-inflammatory agents within
a sample of exercise-trained subjects should consider
using a protocol of longer duration, and possibly higher
intensity, in order to produce a more robust oxidative
stress response. This may allow for a better assessment of
the effectiveness of such nutrient intervention. As our data
show, EPA/DHA intake at the dosage and duration pro-
vided in the present study may serve to combat systemic
inflammation in a sample of exercise-trained men. These
findings may have implications for those who train inten-
sively, as well as other individuals who are prone to
inflammatory conditions, as use of EPA/DHA may prove
beneficial as a non-pharmaceutical anti-inflammatory
agent.
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